To determine if targeted inhibition of monocyte/macrophage NADPH oxidase could mitigate obesity pathology, we generated mice that lack the NADPH oxidase catalytic subunit NOX2 in myeloid lineage cells. The gene discussed is FMO5; the disease is obesity due to melanocortin 4 receptor deficiency.